Zanamivir Versus Trivalent Split Virus Influenza Vaccine

NCT00784784 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Fluviral
DRUG: Zanamivir

Sponsor

Mount Sinai Hospital, Canada

Collaborators

[object Object]